Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Striebich, MD, PhD
University of Colorado School of Medicine
Study Chair - Michael Holers, MD
University of Colorado School of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology
Birmingham, Alabama, United States
- Cedars Sinai Medical Center: Division of Rheumatology
Los Angeles, California, United States
- Ucla Medical Center: Division of Rheumatology
Los Angeles, California, United States
- University of California San Francisco, San Francisco General Hospital
San Francisco, California, United States
- University of Colorado School of Medicine: Division of Rheumatology
Aurora, Colorado, United States
- Emory Clinic at 1365 Clifton Road: Emory University School of Medicine
Atlanta, Georgia, United States
- Brigham & Women'S Hospital: Department of Medicine, Rheumatology, Immunology
Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center: Rheumatology
Worcester, Massachusetts, United States
- University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology
Ann Arbor, Michigan, United States
- Mayo Clinic, Division of Rheumatology
Rochester, Minnesota, United States
- University of Nebraska Medical Center: Division of Rheumatology
Omaha, Nebraska, United States
- Northwell Health
Great Neck, New York, United States
- Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program
Oklahoma City, Oklahoma, United States
- University of Texas Southwestern Medical Center, Division of Rheumatic Diseases
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Apr 2016
- Primary completion
- 1 Nov 2022
- Completion
- 1 Nov 2022
- Last update posted
- 12 Jun 2025
- Registered enrollment
- 144
- Registry id
- NCT02603146
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.